Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Foundation Medicine (FMI)

Foundation Medicine (FMI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Foundation Medicine 150 Second Street Cambridge MA 02141 USA

www.foundationmedicine.com P: 617-418-2200

Description:

Foundation Medicine, Inc. provides molecular information products primarily in the United States. The company offers FoundationOne(TM) a molecular information product for the analysis of routine cancer specimens in a clinical setting. Its molecular information platform generates actionable genomic information about a patient's individual disease, enabling physicians to optimize treatments in clinical practice, and enabling biopharmaceutical companies to develop targeted oncology therapies. Foundation Medicine, Inc. is based in Cambridge, Massachusetts.

Key Statistics

Overview:

Market Capitalization, $K 5,088,180
Shares Outstanding, K 37,140
Annual Sales, $ 152,900 K
Annual Net Income, $ -161,470 K
Last Quarter Sales, $ 52,840 K
Last Quarter Net Income, $ -37,420 K
60-Month Beta -0.09
% of Insider Shareholders 3.00%
% of Institutional Shareholders 33.17%

Growth:

1-Year Return 276.75%
3-Year Return 587.75%
5-Year Return 0.00%
5-Year Revenue Growth 1,335.68%
5-Year Earnings Growth -376.07%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.02 on 05/02/18
Next Earnings Date 08/07/18
Earnings Per Share ttm -4.21
EPS Growth vs. Prev Qtr 2.86%
EPS Growth vs. Prev Year 22.14%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

FMI Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -299.63%
Return-on-Assets % -94.81%
Profit Margin % -105.61%
Debt/Equity 1.90
Price/Sales 33.23
Price/Cash Flow N/A
Price/Book 268.62
Book Value/Share -0.51
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar